Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
about
Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesotheliomaPerspectives on refractory ceramic fiber (RCF) carcinogenicity: comparisons with other fibersGene-environment interactions in the development of complex disease phenotypesWork and its role in shaping the social gradient in healthMesothelioma: Do asbestos and carbon nanotubes pose the same health risk?Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008Malignant pleural mesothelioma in ItalyTheoretical deposition of carcinogenic particle aggregates in the upper respiratory tractEstimating the asbestos-related lung cancer burden from mesothelioma mortalityBUILDING NEW KNOWLEDGECompensation for environmental asbestos-related diseases in South Africa: a neglected issueThe effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma.Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomicsSusceptibility and resistance in the genesis of asbestos-related mesothelioma.Pleural and peritoneal mesotheliomas in the Friuli Venezia Giulia register: data analysis from 1995 to 2015 in Northeastern Italy.Risk Factors of Mortality from All Asbestos-Related Diseases: A Competing Risk AnalysisMalignant peritoneal mesothelioma - a rare cause of laparotomy.Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene.A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma.Malignant pleural mesothelioma: an epidemiological perspectiveShipbuilding and mesothelioma in Monfalcone, Italy.Computerized segmentation and measurement of malignant pleural mesothelioma.Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1).Phenotypes and karyotypes of human malignant mesothelioma cell lines.Global mesothelioma epidemic: Trend and features.Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma.NF2 blocks Snail-mediated p53 suppression in mesothelioma.The Role of Regulatory T Cells in Mesothelioma.Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion.Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patientsSMO expression level correlates with overall survival in patients with malignant pleural mesothelioma.Malignant pleural mesothelioma in a 17-year old boy: A case report and literature review.No detection of simian virus 40 in malignant mesothelioma in Korea.Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factorsIs there a role of immunosenescence in the pathogenesis of malignant mesothelioma? A case studyMalignant mesothelioma incidence by nation-wide cancer registry: a population-based studyThe latency period of mesothelioma among a cohort of British asbestos workers (1978-2005)Mesothelioma epidemiology, carcinogenesis, and pathogenesis.An Integrated Analysis of the Genome-Wide Profiles of DNA Methylation and mRNA Expression Defining the Side Population of a Human Malignant Mesothelioma Cell Line.
P2860
Q24607747-3F7E83E3-16AC-4D9C-8355-C4EEDA4E3A35Q28383101-E47DC985-ED8F-4BAC-8C1D-09FC8189EA73Q28384468-FDB4A13F-B1AB-4BCF-8B69-BFE9A9DB397EQ28385305-F8DC7AF5-1CDB-4CF2-893A-D063506873C1Q28389608-7165A6DE-C46C-4E04-9B92-671C0A348B71Q28393456-CF202A7E-E1F7-495C-8DB0-14917BE24714Q28394535-288591E2-88B6-4E84-ADB3-63F5E11514FAQ28396039-07493443-E0B7-4F9F-8C3F-8CB70E4287FEQ28396373-3BEF1B57-188A-4A79-B28E-9F73F52ED835Q29248576-99038360-FD4A-4CC5-8893-0BDB559E5711Q29248577-20DC6562-0F7E-4AFF-A3B6-6507AC5407F0Q30498202-12425C41-BBBD-4D2F-9C72-9E265D7144A0Q30843287-798CF68E-3E83-4F62-AE37-AA3BAD6DFD28Q33551580-EE8CBA83-115E-42C6-9727-4EA6F64C9BD0Q33639232-71EB5828-00A5-44C5-91BE-36AB665B1DD3Q33819781-FDFEDA92-A0A3-4A54-8422-DEA42B137AD8Q33871712-8860457F-89C1-47FB-AE46-38F40AAD45D4Q33887850-4F07C340-51BD-4123-9CAB-D29FF114B126Q34018570-6C15CC7E-A2E5-4664-B3FB-C026907B60C4Q34366730-8AED8212-93EC-4C0F-9AE6-96AAB3E3EBEEQ34462052-1868F836-611B-4438-9E21-AB9ECF03A2ECQ34493719-603F59EE-284E-4B0B-A8BB-612B821535C7Q34520155-9C483AB3-FB92-4A25-B3BB-338367ABAB5FQ34629469-629BF2AC-AD01-4E51-82D7-E931302C1762Q34794519-851CECE5-BC90-4E05-9628-296ADB741BF6Q35699080-9382D891-D58D-45CA-A290-D1872D2A71F4Q35832918-B093EC2E-7145-4DB8-A5E6-54E0ACAE6D5EQ36101238-2FB5397D-60FC-400E-860A-5B3FFF02F77DQ36159154-D9067FEB-FB88-460B-B414-D0964E8C239AQ36228527-06B40E1F-C330-4DA9-BB8F-8546A8116ADDQ36286635-78800F31-5B0E-4365-BF5B-47125E8D603FQ36755534-2E260B00-24BB-4A02-B5AF-599D9256B67BQ36766690-8CE52A08-1FB4-471C-BF01-1307F0ED0F52Q36824375-29E16739-3593-415A-9546-5B6806D4C243Q36828498-8608E820-6F47-4FC4-8325-0DD889DA8280Q36872224-36870A93-E7FA-42CD-980E-43170987406CQ37126051-61C150FA-346F-4E27-BADE-8D4173B0E1FFQ37214282-AF37A90B-6265-4A47-8F40-0D12A60A2F60Q37246002-6FC2BE54-9B6D-45B1-8029-50B605C12D6DQ37290552-C4781870-2D6B-4836-9980-7A35FCE71DFE
P2860
Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
@ast
Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
@en
Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
@en-gb
type
label
Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
@ast
Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
@en
Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
@en-gb
prefLabel
Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
@ast
Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
@en
Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
@en-gb
P3181
P356
P1433
P1476
Malignant Mesothelioma: Global Incidence and Relationship with Asbestos
@en
P2093
Claudio BIANCHI
Tommaso BIANCHI
P304
P3181
P356
10.2486/INDHEALTH.45.379
P577
2007-01-01T00:00:00Z